ArticleBMC cancer2021

Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy.

Shanshan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.